Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.

MLA

van de Meeberg, Maartje M., et al. “Therapeutic Drug Monitoring of Methotrexate in Patients with Crohn’s Disease.” Alimentary Pharmacology & Therapeutics, vol. 58, no. 11–12, Dec. 2023, pp. 1151–62. EBSCOhost, https://doi.org/10.1111/apt.17719.

APA

van de Meeberg, M. M., Fidder, H. H., Oldenburg, B., Sundaresan, J., Struys, E. A., Montazeri, N. S. M., Mares, W. G. N., Mahmmod, N., van Asseldonk, D. P., Lutgens, M. W. M. D., Kuyvenhoven, J. P., Rietdijk, S. T., Nissen, L. H. C., Koehestanie, P., de Boer, N. K. H., de Jonge, R., Bouma, G., & Bulatović Ćalasan, M. (2023). Therapeutic drug monitoring of methotrexate in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics, 58(11–12), 1151–1162. https://doi.org/10.1111/apt.17719

Chicago

van de Meeberg, Maartje M, Herma H Fidder, Bas Oldenburg, Janani Sundaresan, Eduard A Struys, Nahid S M Montazeri, Wout G N Mares, et al. 2023. “Therapeutic Drug Monitoring of Methotrexate in Patients with Crohn’s Disease.” Alimentary Pharmacology & Therapeutics 58 (11–12): 1151–62. doi:10.1111/apt.17719.